With the analysis among 9,395 patents, we discovered top 449 key players by total patent application. Bristol Myers Squibb Co., Pharmacia Corp., Pfizer Inc. are dominant in this area. They take 10.56% of the total patent filing.
New York, United States
Patent: 425
New Jersey, United States
Patent: 292
New York, United States
Patent: 275
Connecticut, United States
Patent: 246
Hounslow, United Kingdom
Patent: 239
Basel-Stadt, Switzerland
Patent: 190
Achillion Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 188
F. Hoffmann-La Roche Ltd.
Washington, United States
Patent: 178
With the analysis among 245 patents, we discovered top 25 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, GenFleet Therapeutics (Shanghai) Co., Ltd., HepaRegeniX GmbH are active in this area.
Institut National de la Santé et de la Recherche Médicale
GenFleet Therapeutics (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 43
Baden-Württemberg, Germany
Patent: 19
Essex, United Kingdom
Patent: 12
Regenacy Pharmaceuticals LLC
Massachusetts, United States
Patent: 9
New York, United States
Patent: 8
California, United States
Patent: 7
With the analysis among related 1,956 patents applied in the last 5 years. We discover 495 most active companies in this area. The fast-growing Yuhan Corp., Prelude Therapeutics, Inc., Bristol Myers Squibb Co. take 9.92% of patent filing during this period.
Prelude Therapeutics, Inc.
Delaware, United States
Patent: 62
New York, United States
Patent: 55
GenFleet Therapeutics (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 43
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 37
Zhejiang Jinfang Pharmaceutical Co Ltd
Zhejiang Sheng, China
Patent: 37
Shanghai Zejing Pharmaceutical Technology Co Ltd
Shanghai Shi, China
Patent: 35
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 30
Massachusetts, United States
Patent: 30
Blueprint Medicines Corp.
Massachusetts, United States
Patent: 29
With the analysis among related 1,956 patents in last 5 years, we discover 280 new entrants. GenFleet Therapeutics (Shanghai) Co., Ltd., Zhejiang Jinfang Pharmaceutical Co Ltd, Suzhou Zelgen Biopharmaceuticals Co., Ltd. are the most active new entrants in this area.
GenFleet Therapeutics (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 43
Zhejiang Jinfang Pharmaceutical Co Ltd
Zhejiang Sheng, China
Patent: 37
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 37
Shanghai Zejing Pharmaceutical Technology Co Ltd
Shanghai Shi, China
Patent: 35
Massachusetts, United States
Patent: 30
Aurigene Discovery Technologies Ltd.
Karnataka, India
Patent: 28
Lombardia, Italy
Patent: 21
Shouyao Holdings (Beijing) Co. Ltd.
Beijing Shi, China
Patent: 19
Baden-Württemberg, Germany
Patent: 19
With the analysis among 1,910 patents, we discovered top 269 universities and scientific research institutions by total patent application. Simon Fraser University, Katholieke Universiteit Leuven, Emory University are dominant in this area. They take 11.73% of the total patent filing.
British Columbia, Canada
Patent: 46
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 46
Georgia, United States
Patent: 35
Illinois, United States
Patent: 34
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 31
The Johns Hopkins University
Tennessee, United States
Patent: 27
Regents of the University of Colorado
Colorado, United States
Patent: 27
University of Southern California
California, United States
Patent: 25
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 25